Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
76-22-2
Molecular formula
C10H16O
Molecular weight
152.23 g/mol
Drug class
Topical counterirritantterpene ketone used in external analgesic preparations
Mechanism of action
Produces a local cooling and counterirritant sensation through effects on transient receptor potential (TRP) channels in cutaneous sensory neurons. The perceived cooling and counterirritant response can transiently reduce awareness of superficial pain or itching.
Indications / reported uses
Temporary relief of minor muscle and joint aches when used in topical external analgesic products
Symptomatic relief of minor itching or irritation in selected topical formulations; do not apply to broken skin or use by ingestion
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Camphor PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Camphor Permitted Daily Exposure (PDE) report (the Camphor PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Camphor Occupational Exposure Limit (OEL) report (the Camphor OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.